Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 6,064 |
|
|||||
| News | - | ||||||
| Day High | 0.675 | Low High |
|||||
| Day Low | 0.6401 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Monopar Therapeutics Inc | MNPR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.01025 | 1.55% | 0.670349 | 11:11:20 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.65 | 0.6401 | 0.675 | 0.660101 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 43 | 6,064 | US$ 0.6591505 | US$ 3,997 | - | 0.2739 - 1.75 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:50:48 | 14 | US$ 0.660501 | USD |
Monopar Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9.96M | 14.87M | - | 0 | -8.4M | -0.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Monopar Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/18/2024 | 07:00 | GlobeNewswire Inc. | Monopar Announces Radiopharma Presentation Selected for.. |
| 4/16/2024 | 07:00 | GlobeNewswire Inc. | Monopar Announces Filing of Patent Protecting MNPR-101.. |
| 4/10/2024 | 07:00 | GlobeNewswire Inc. | Monopar Initiates Radiopharma Phase 1 Clinical Trial for.. |
| 3/28/2024 | 06:00 | GlobeNewswire Inc. | Monopar Reports Fourth Quarter and Full-Year 2023 Financial.. |
| 3/07/2024 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/05/2024 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/05/2024 | 06:00 | GlobeNewswire Inc. | Monopar Announces Positive Preclinical Therapeutic Isotope.. |
| 2/28/2024 | 12:45 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/27/2024 | 06:00 | GlobeNewswire Inc. | Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical.. |
| 2/27/2024 | 05:59 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/22/2024 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/22/2024 | 06:00 | GlobeNewswire Inc. | Monopar Announces Promising Preclinical Data for its.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MNPR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.68 | 0.69 | 0.62 | 0.6492798 | 40,000 | -0.00965 | -1.42% |
| 1 Month | 0.63 | 0.85 | 0.4999 | 0.6937173 | 155,416 | 0.04035 | 6.40% |
| 3 Months | 0.3205 | 1.73 | 0.309 | 1.01 | 5,865,354 | 0.34985 | 109.16% |
| 6 Months | 0.6617 | 1.73 | 0.2739 | 0.9263391 | 3,294,535 | 0.00865 | 1.31% |
| 1 Year | 1.09 | 1.75 | 0.2739 | 0.9285211 | 1,769,590 | -0.41965 | -38.50% |
| 3 Years | 6.01 | 6.98 | 0.2739 | 1.03 | 605,877 | -5.34 | -88.85% |
| 5 Years | 24.14 | 48.00 | 0.2739 | 1.63 | 446,136 | -23.47 | -97.22% |
Monopar Therapeutics Description
| Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers. |
